Panacea Biotec announced its collaboration with Refana Inc for the COVID vaccine (representative)
Bengaluru:
Biotech company Panacea Biotec Ltd announced Wednesday that it will partner with US company Refana Inc to manufacture a potential vaccine against COVID-19.
The collaboration aims to manufacture more than 500 million doses of the candidate vaccine, and more than 40 million doses are expected to be available early next year, Panacea said in a stock market statement.
Panacea shares jumped 20% during morning trading on the National Stock Exchange after the news.
